BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29563163)

  • 1. Anti-
    Lombardo GE; Maggisano V; Celano M; Cosco D; Mignogna C; Baldan F; Lepore SM; Allegri L; Moretti S; Durante C; Damante G; Fresta M; Russo D; Bulotta S; Puxeddu E
    Mol Cancer Ther; 2018 Jun; 17(6):1187-1195. PubMed ID: 29563163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells.
    Maggisano V; Celano M; Lombardo GE; Lepore SM; Sponziello M; Rosignolo F; Verrienti A; Baldan F; Puxeddu E; Durante C; Filetti S; Damante G; Russo D; Bulotta S
    Mol Cell Endocrinol; 2017 Jun; 448():34-40. PubMed ID: 28288903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.
    Kim S; Youn H; Song MG; Kang JH; Chung HK; Lee DS; Chung JK
    Cancer Gene Ther; 2012 Apr; 19(4):263-70. PubMed ID: 22301953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo.
    Xie M; Chen Q; He S; Li B; Hu C
    Oncol Rep; 2011 Oct; 26(4):1019-27. PubMed ID: 21743972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of silencing hTERT gene on growth of human squamous cell carcinoma xenograft in nude mice].
    Yao X; Wang X; Zhang S; Yan L; Zhu H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 25(20):939-43. PubMed ID: 22239057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
    Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
    Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
    Zhang K; Yu M; Hao F; Dong A; Chen D
    Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
    Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
    Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
    Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
    Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
    Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
    Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
    Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
    Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.
    Garg M; Kanojia D; Okamoto R; Jain S; Madan V; Chien W; Sampath A; Ding LW; Xuan M; Said JW; Doan NB; Liu LZ; Yang H; Gery S; Braunstein GD; Koeffler HP
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E62-72. PubMed ID: 24170107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
    Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
    Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
    Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
    J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.